Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

MSRXX vs. MIEKX: which is better?

Bottom line

MSRXX vs MIEKX: the short answer

MSRXX (MFS U.S. Government Cash Reserve Fund) and MIEKX (MFS International Equity Fund) are both money market funds.

MSRXX is cheaper at 0.45% vs 0.7% — a difference of $25 a year per $10,000 invested.

Over five years, MIEKX returned +8.4% a year vs +2.1% for MSRXX (reporting dates differ).

Updated Nov 19, 2026

MSRXX vs MIEKX side by side

MSRXXMIEKX
TypeMoney market fundMutual fund
Fund familyMFSMFS
CategoryMoney MarketInternational Stock
Expense ratio0.45%0.7%
Annual cost per $10k$45$70
10-yr cost on $10k (prospectus)$990$882
Max front load0%0%
12b-1 fee0.25%0%
1-yr return+4.9%+23.1%
5-yr return (annualized)+2.1%+8.4%
10-yr return (annualized)+1.4%+9.4%
Best quarter+1.3%—
Worst quarter0.0%—
Net assets (fund)—$28.9B
Number of holdings—83
Portfolio turnover—25%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

MSRXX and MIEKX share none of their top holdings.

MSRXX top 10

    MIEKX top 10

    1. Taiwan Semiconductor Manufacturing Co. Ltd. — 4.42%
    2. Novartis AG — 2.83%
    3. Roche Holding AG — 2.78%
    4. Schneider Electric SE — 2.61%
    5. Air Liquide SA — 2.50%
    6. Rolls-Royce Holdings plc — 2.42%
    7. Cie Financiere Richemont SA — 2.34%
    8. BNP Paribas SA — 2.32%
    9. Hitachi Ltd. — 2.16%
    10. Mitsubishi Electric Corp. — 2.15%

    FAQ

    What is the difference between MSRXX and MIEKX?
    MSRXX (MFS U.S. Government Cash Reserve Fund) and MIEKX (MFS International Equity Fund) are both money market funds. MSRXX is cheaper at 0.45% vs 0.7% — a difference of $25 a year per $10,000 invested.
    Which is cheaper, MSRXX or MIEKX?
    MSRXX has the lower expense ratio (0.45%).
    Should I own both MSRXX and MIEKX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.